NBH Lifetime Health is now offering the new combination fat reduction pill that is currently pending FDA approval. It is a combination of phentermine and topiramate. These two drugs are FDA approved individually for appetite control (phentermine) and as an anti-convulsant (topiramate). They have been combined under the name Qnexa to act as an appetite suppressant and satiety pill. *Clinical studies show a 10% to 15% reduction in weight.
This combination has been prescribed “off label” for some time in certain clinics in California and we have staff tested it in our clinics and with select patients on a short term basis. I described this combination pill in my book, the Diet Secrets (in chapter 17 discussing the future of weight reduction.)
A FDA advisory panel of 22 providers has recommended approval (20 of the 22 providers) of Qnexa. The FDA is expected to rule by April 17th. The FDA generally follows the recommendation of the advisory panel but not always.
IT IS CONTRAINDICATED FOR WOMEN WHO COULD BECOME PREGNANT WHILE TAKING THE WEIGHT REDUCTION COMBINATION PILL. See below and blog article for details on Qnexa.
Medical Weight Loss Gold Program, Introductory Offer: $299.00.
This new combination weight reduction pill is now being offered as part of our new Medical Weight Loss Gold Program.
The program includes all of the following:
30 Day Supply of Combination Weight Loss Pill
PhytoMulti (60 caps)
Probiotic (60 caps)
Lipo-Plex Plus Injection
In-Body Total Fat, Muscular, Skeletal, and Water Analysis
Baseline Body Measurements
The NBH Lifetime Health Weight Loss & Bioidentical Hormone Booklet.
Healthy Eating Guide
Note: Monthly Renewal Fee: $159.00. Includes prescription combination pill, Lipo-Plex Plus injection, consultation, body composition analysis, measurements, and adjustments as needed.